Professor of Pediatrics, University Alabama
Pediatric Nephrology
Dr. Mark R. Benfield, MD
|
|
Give Review
Mark R. Benfield is an expert in the field of Pediatric Nephrology. He studied medicine at University of Alabama Medical Center. University of Alabama Medical Center is ranked 37/17 in Research/PrimaryCare. He received 1 awards: "America's Top Doctors". Mark R. Benfield, MD is a published physician as well. He has 52 publications published. The latest was: Therapy of focal and segmental glomerulosclerosis with methylprednisolone, cyclosporine A, and prednisone. He is registered with Medicare.
Publications
- The Clinical Impact of Humoral Immunity in Pediatric Renal Transplantation.
- Correlation and clinical utility of pp65 antigenemia and quantitative polymerase chain reaction assays for detection of cytomegalovirus in pediatric Renal transplant p...
- Demographic characteristics of pediatric continuous Renal replacement therapy: a report of the prospective pediatric continuous Renal replacement therapy registry.
- Current status of Kidney transplant: update 2003.
- Metabolic Abnormalities, Cardiovascular Disease Risk Factors, and GFR Decline in Children with Chronic Kidney Disease.
- The relationship between ethnicity and outcomes in solid organ transplantation.
- Insurance, non-adherence--a call to action.
- Time to automate identification.
- Fluid overload and mortality in children receiving continuous Renal replacement therapy: the prospective pediatric continuous Renal replacement therapy registry.
- Sleep and fatigue symptoms in children and adolescents with CKD: a cross-sectional analysis from the chronic Kidney disease in children (CKiD) study.
- Continuous Renal replacement therapy (CRRT) after stem cell transplantation. A report from the prospective pediatric CRRT Registry Group.
- Racial differences in graft survival: a report from the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS).
- Sequential analysis of the lipid profile of children post-Renal transplantation.
- Comment on 'The effect of rhGH in vitro on donor-specific hyporesponsiveness in Pediatric transplantation.
- Baking soda: a potentially fatal home remedy.
- What is the role for mycophenolate mofetil in pediatric Renal transplantation?
- An unusual case of peritoneal dialysis malfunction.
- Sirolimus pharmacokinetics in pediatric Renal transplant recipients receiving calcineurin inhibitor co-therapy.
- Are the Banff 97 criteria for Renal allograft biopsy specimen adequacy achievable in children?
- A randomized multicenter trial of OKT3 mAbs induction compared with intravenous cyclosporine in pediatric Renal transplantation.
- Changing trends in pediatric transplantation: 2001 Annual Report of the North American Pediatric Renal Transplant Cooperative Study.
- Pediatric hemofiltration: Normocarb dialysate solution with citrate anticoagulation.
- Protein and calorie prescription for children and young adults receiving continuous Renal replacement therapy: a report from the Prospective Pediatric Continuous Renal...
- Improved survival with recent Post-Transplant Lymphoproliferative Disorder (PTLD) in children with Kidney transplants.
- Pediatric transplantation in the United States, 1997-2006.
- Mycophenolate mofetil in pediatric Renal transplantation.
- Trends in immunosuppressive therapy: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).
- The effect of rhGH in vitro on donor-specific hyporesponsiveness in Pediatric transplantation.
- Pediatric transplant grand rounds.
- A "minimal signal-stepwise activation" analysis of functional maturation of T lymphocytes.
- Human anti-murine mixed leukocyte culture: effects of cytokines.
- Methylprednisolone treatment of patients with steroid-resistant Nephrotic syndrome.
- Pediatric Renal transplantation: indications and special considerations. A position paper from the Pediatric Committee of the American Society of Transplant Physicians.
- Safety of Kidney biopsy in pediatric transplantation: a report of the Controlled Clinical Trials in Pediatric Transplantation Trial of Induction Therapy Study Group.
- Therapy of focal and segmental glomerulosclerosis with methylprednisolone, cyclosporine A, and prednisone.
- Growth hormone induces interferon gamma production and may play a role in the presentation of alloantigens in vitro.
- Growth hormone is safe in children after Renal transplantation.
- The effect of recombinant human growth hormone on responses to alloantigens in the Pediatric transplant patient.
- Treatment of growth Failure in children after renal transplantation.
- Murine APC activation in the xenogeneic MLC.
- Treatment of IgA nephropathy in children: efficacy of alternate-day oral prednisone.
- Growth hormone in the treatment of growth Failure in children after renal transplantation.
- Recombinant human growth hormone augments responses in the mixed leukocyte culture.
- The effect of changes in dialysate volume on glucose and urea equilibration.
- Association of cytokine single nucleotide polymorphisms with B7 costimulatory molecules in Kidney allograft recipients.
- Increased costimulatory responses in African-American Kidney allograft recipients.
- Increased nuclear factor-kappaB and angiotensinogen gene expression in posttransplant recurrent focal segmental glomerulosclerosis.
- Peripheral blood antigen-presenting cells from African-Americans exhibit increased CD80 and CD86 expression.
- The 1997 Annual Renal Transplantation in Children Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).
- A randomized double-blind, placebo controlled trial of steroid withdrawal after pediatric Renal transplantation.
- The effect of vascular access location and size on circuit survival in pediatric continuous Renal replacement therapy: a report from the PPCRRT registry.
Schools
Tulane University School Of Medicine
Chldns Hospital
University Of Minnesota
Tulane U
Procedures Preformed
- Ambulatory Blood Pressure Monitoring
- Biopsy
- Kidney Stones Treatment
- Kidney Transplant
- View All
Conditions Treated
- Acidosis
- Acute Glomerulonephritis
- Acute Kidney Failure
- Alkalosis
- View All
Doctors Specialties
- Pediatric Nephrology
Accepted Insurances
Awards
- America's Top Doctors
Education
-
University of Minnesota at Fairview -
University of Alabama Medical Center -
Tulane University School of Medicine
Hospital
-
Children's of Alabama
Drug Facts
| NPI NUMBER | 1811004245 | |
| NPPES Provider LastName | BENFIELD | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 352053898 | |
| NPPES Provider State | AL | |
| Specialty Description | Pediatric Medicine | |
| Total Claim Count | 305.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1811004245 |
| Last Name Of The Provider | BENFIELD |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
Dr. Frank B. Waldo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Askenazi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa Guay-Woodford, MD |
|
|
Dr. Sahar A. Fathallah-Shaykh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ramzi A. Malek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Megan V. Yanik, MD |
|
|
Dr. William F. Tenney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel Feig, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|